✦ LIBER ✦

Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy

✍ Scribed by Follmer, Cristian

Book ID: 121852498
Publisher: Expert Reviews
Year: 2014
Tongue: English
Weight: 885 KB
Volume: 14
Category: Article
ISSN: 1473-7175
DOI: 10.1586/14737175.2014.920235

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

α-Synuclein phosphorylation as a therape

α-Synuclein phosphorylation as a therapeutic target in Parkinson’s disease

✍ Braithwaite, Steven P.; Stock, Jeffry B.; Mouradian, M. Maral 📂 Article 📅 2012 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 117 KB

1.2.3 MISFOLDED α-SYNUCLEIN AND NEUROINF

1.2.3 MISFOLDED α-SYNUCLEIN AND NEUROINFLAMMATION AS THERAPEUTIC TARGETS FOR PARKINSON'S DISEASE

✍ K.A. Maguire-Zeiss 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A rationale for monoamine oxidase inhibi

A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease

✍ Prof. C. W. Olanow 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

Neurons in the substantia nigra may be vulnerable to oxidant stress because (a) the metabolism of dopamine generates peroxides. which, in the presence of iron. can lead to the formation of the highly reactive hydroxyl free radical; and (b) neuromelanin within nigral neurons can bind metals such as i

Recent advances in Parkinson’s disease t

Recent advances in Parkinson’s disease therapy: use of monoamine oxidase inhibitors

✍ Henchcliffe, Claire; Schumacher, H Christian; Burgut, F Tuna 📂 Article 📅 2005 🏛 Expert Reviews 🌐 English ⚖ 186 KB

Misfolded α-synuclein and toll-like rece

Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease

✍ Dawn Béraud; Kathleen A. Maguire-Zeiss 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Environmental toxins and α-synuclein in

Environmental toxins and α-synuclein in Parkinson’s disease

✍ Yanying Liu; Hui Yang 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 96 KB